Sort
35,931 grants matching “parkinsons”
Structures and biological activity of alpha-synuclein aggregation
$335,083Lin Jiang · University Of California Los Angeles · R01 · FY2019 · AG
Novel Neuroprotection by Caffeine in Parkinson's Disease
$335,050Massachusetts General Hospital · R01 · FY2005 · ES
Novel Neuroprotection by Caffeine in Parkinson's Disease
$335,050Massachusetts General Hospital · R01 · FY2003 · ES
Novel Neuroprotection by Caffeine in Parkinson's Disease
$335,050Massachusetts General Hospital · R01 · FY2004 · ES
Combined neuroprotection and metabolic correction to treat leukodystrophies
$335,027Ernesto Roque Bongarzone · University Of Illinois At Chicago · R01 · FY2010 · NS
In vivo agonist molecular probes for the dopamine D1 receptor
$335,014Richard B Mailman · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2018 · NS
Coordinating mitochondrial network expansion and longevity via the Integrated Stress Response (ISR)
$335,000Cole Michael Haynes · Univ Of Massachusetts Med Sch Worcester · R56 · FY2022 · AG
A Novel Neuroprotective Protein, Thorase
$334,970Valina L. Dawson · Johns Hopkins University · R01 · FY2008 · AG
A Novel Neuroprotective Protein, Thorase
$334,970Valina L. Dawson · Johns Hopkins University · R01 · FY2009 · AG
RISK FACTORS FOR HIP FRACTURES AMONG THE ELDERLY
$334,910Mayo Clinic Coll Of Medicine, Rochester · P01 · FY2000 · AG
Structural biology of enzymes in fatty acid metabolism
$334,888Liang Tong · Columbia Univ New York Morningside · R01 · FY2012 · DK
Structural biology of enzymes in fatty acid metabolism
$334,888Liang Tong · Columbia Univ New York Morningside · R01 · FY2011 · DK
Norepinephrine-dopamine interactions underlying arousal
$334,836David Weinshenker · Emory University · R01 · FY2020 · NS
In vivo chemical monitoring using capillary separations
$334,812Robert T Kennedy · University Of Michigan At Ann Arbor · R01 · FY2019 · EB
Bioengineering of a New Antibody Drug Delivery Technology
$334,803Ruben J. Boado · Armagen Technologies, Inc. · R44 · FY2011 · MH
BINDING SITE STRUCTURE OF NEURONAL NICOTINIC RECEPTORS
$334,796University Of Miami School Of Medicine · R01 · FY2002 · DA
INVESTIGATIONS OF HUMAN PRION DISEASE
$334,786Stanley B Prusiner · University Of California, San Francisco · P01 · FY2011 · AG
ATP13A2 and Susceptibility to Neurodegeneration
$334,767Sheila Fleming · Northeast Ohio Medical University · R01 · FY2020 · ES
ATP13A2 and Susceptibility to Neurodegeneration
$334,767Sheila Fleming · Northeast Ohio Medical University · R01 · FY2021 · ES
Multiple Approaches to Abeta Vaccination in Animal Models
$334,765David Hastings Cribbs · University Of California-Irvine · R01 · FY2014 · AG
Multiple Approaches to Abeta Vaccination in Animal Models
$334,765David Hastings Cribbs · University Of California-Irvine · R01 · FY2016 · AG
Efficient statistical methods for assessing dementia risk in Parkinson's disease
$334,756Sharon Xiangwen Xie · University Of Pennsylvania · R01 · FY2017 · NS
Stem Cell Adaptability in Parkinson'Disease
$334,747University Of Kentucky · R01 · FY2005 · NS
Mitochondrial Aconitase and Parkinson's Disease
$334,745University Of Colorado Denver · R01 · FY2004 · NS
Nicotinic Receptors in Parkinson's Disease
$334,716Parkinson'S Institute · R01 · FY2004 · NS